GSK Investigational Site

Puebla, Pue, Puebla 72000

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD — Completed
• Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children — Completed